BCM
RDY icon

Brookstone Capital Management’s Dr. Reddy's Laboratories RDY Stock Holding History

Brookstone Capital Management’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-1,000
Closed -$13K – 713
2015
Q3 		$13K Hold
1,000
– – ﹤0.01% 989
2015
Q2 		$11K Buy
+1,000
New +$11K ﹤0.01% 1145

Other funds holding RDY

Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
CBOA
Commonwealth Bank of Australia Sydney, NSW, Australia $231M AUM
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VAM
Vontobel Asset Management New York $18.1B AUM 28.09% 1-Year Est. Return
BG
BlackRock Group London, United Kingdom $210B AUM 15.5% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Brookstone Capital Management's RDY Position: Q4 2015 in Review

Brookstone Capital Management sold out of Dr. Reddy's Laboratories (RDY) in Q4 2015, closing a stake of 1,000 shares — an estimated $13K sold.

Brookstone Capital Management first reported a position in RDY in Q2 2015 and held it in 2 quarters. The position peaked at $13K in Q3 2015. 174 funds tracked by Wall St. Rank hold RDY as of Q4 2015.

  • Brookstone Capital Management reported no remaining Dr. Reddy's Laboratories position as of Q4 2015 after selling out during the quarter.
  • Brookstone Capital Management sold 1,000 Dr. Reddy's Laboratories shares in Q4 2015, an estimated $13K.
  • Brookstone Capital Management first reported a position in Dr. Reddy's Laboratories in Q2 2015 and held it in 2 quarters.
  • Brookstone Capital Management's Dr. Reddy's Laboratories position peaked at $13K in Q3 2015.
  • 174 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q4 2015.

Based on Brookstone Capital Management's 13F filing for Q4 2015, filed 14 Jan 2016.